Member Info for matarakz

For long term investors here, let us limit our posting here , what we need here is stability and confidence of true investors here. We just want to be Batm, stable and few are posting every day and yet it is bullish.imho

GGP has almost half a billion market cap without DFS . Eua is very undervalued company imho.

Squeeze is coming! I feel sorry for the shorters, it is called karma. Imho

Patience is the key. Not too long now ,hopefully we would have an amicable settlement.

Any leak?

Please don’t ramp too much. Revenue is different from sales/order . My half year revenue target is between £80-100 million but full year revenue is between £300-400 million. Imho

Novacyt
No debt
No dilution
Mortgage free
Board of directors bought shares above£3
More than £120 million sales
Covid 19 production 10 million a month
My projected revenue year end £300-500 million
Net profit more than £100 million
Majority of Aim companies love dilution and issue of equities.
Very undervalued company. Imho

Maybe Leak!

Neodymium expected price $41,000 per metric ton
Praseudymium expected price $52,000 per metric ton

China, russia, usa are fighting for rare earth elements.

Yangibana mining is a valuable asset to Cadence. In the future , it would follow Eua .

Nothing to worry maddog! Day trading is part of the business and and profit takers are expected. What we are waiting for is the big news ‘the Amapa ruling’.

Once Amapa ruling is favourable to the joint venture then it is possibrl. Majority of court decisions do not change their previous court rulings . Imho it is favourable to Cadence and co.

It was a massive Rns!

To New investors
Final results was already reported on the 14 of may. The rns today was just a annual financial publication.
The share was downed today due to profit takers. It was up 12% yesterday . Imho

Hopefully over a thousand of q16 and q32 units sold is possible this year. Imho

‘Expected to increase significantly in 2020’ from the Annual report

The q32 instrument list price is approximately €13,500 per unit. Since its launch in 2015, Primerdesign has sold over 450 q16 instruments, which lists at €5,500 per unit, and has generated more than €2.0 million in revenues. During 2019, sales of q16 instruments were lower than 2018 due to lack of stock, but are expected to increase significantly in 2020.

Novacyt
No debt
No dilution
Mortgage free
Board of directors bought shares above£3
More than £120 million sales
Covid 19 production 10 million a month
My projected revenue year end £300-500 million
Net profit more than £100 million
Majority of Aim companies love dilution and issue of equities.
Very undervalued company. Imho

Thanks God! France is 5% up.

Thanks God! UK is moving now

France is almost 7% up

https://www.fiercebiotech.com/medtech/as-problems-grow-abbott-s-fast-covid-19-test-fda-standards-are-under-fire
Be proud of Novacyt’s accurate test. Well done to the company’s BOD.